Real-World Clinical Outcomes Associated with Canagliflozin in Patients with Type 2 Diabetes Mellitus in Spain: The Real-Wecan Study

por Gorgojo-Martínez, Juan J., Gargallo-Fernández, Manuel A., Galdón Sanz-Pastor, Alba, Antón-Bravo, Teresa, Brito-Sanfiel, Miguel, Wong-Cruz, Jaime
Publicado 2020

Predictive Factors of Renal Function Decline in Patients with Type 2 Diabetes Treated with Canagliflozin in the Real-Wecan Study

por Gorgojo-Martinez, Juan J., Brito-Sanfiel, Miguel, Antón-Bravo, Teresa, Galdón Sanz-Pastor, Alba, Wong-Cruz, Jaime, Gargallo Fernández, Manuel A.
Publicado 2022